CD80 and CD86 costimulatory molecules on circulating T cells of HIV infected individuals

Immunology Letters

Volumn 65, Issue 3, 1999, Pages 197-201

  Köchli, Christine ^a   Wendland, Thomas ^a   Frutig, Karin ^a   Grunow, Roland ^a   Merlin, Steven ^a   Pichler, Werner J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

CD28; CD80; CD86; HIV infection; HLA DR

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; GLYCOPROTEIN GP 120; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VIRUS RNA;

ADULT; ANTIGEN PRESENTING CELL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ADULT; ANTIGEN PRESENTATION; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, CD86; CD4-POSITIVE T-LYMPHOCYTES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HLA-DR ANTIGENS; HUMANS; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; RNA, VIRAL; T-LYMPHOCYTES;

EID: 0032974046     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2478(98)00107-2     Document Type: Article

References (25)

1. Germain R.N., Margulies D.H. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11:1993;403-451.
2. Freeman G.J., Freedman A.S., Segil J.M., Lee G., Whitman J.F., Nadler L.M. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143:1989;2714-2722.
3. Linsley P.S., Ledbetter J.A. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:1993;191-212.
4. Gimmi C.D., Freeman G.L., Gibben J.G., Gray G., Nadler L.M. Human T cell clonal anergy is induced by antigen presentation in the absence of B7 costimmulation. Proc. Natl. Acad. Sci. USA. 90:1993;6586-6590.
5. Linsley P.S., Brady W., Urnes M., Grosmaire L.S., Damle N.K., Ledbetter J.A. CTLA4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174:1991;561-570.
6. Walunas T.L., Lenschow D.J., Bakker C.Y. et al. CTLA4 can function as a negative regulator of T cell activation. Immunity. 1:1994;405-415.
7. Gribben J.G., Freeman G.J., Boussiotis V.A. et al. CTLA4 mediates antigen-specific apoptosis of human T cells. Proc. Natl. Acad. Sci. USA. 92:1995;811-815.
8. Larsen C.P., Ritchie S.C., Hendrix R. et al. Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2). Expression on murine dendritic cells. J. Immunol. 152:1994;5208-5219.
9. Rattis F.M., Péguet-Navarro J., Staquet M.-J., Dezutter-Dambuyant C., Courtellemont P., Redziniak G., Schmitt D. Expression and function of B7-1 (CD80) and B7-2 (CD86) on human epidermal Langerhans cells. Eur. J. Immunol. 26:1996;449-453.
10. Nickolff B., Mitra R., Lee K., Turka L., Green J., Thompson G., Shimizu Y. Discordant expression of CD28 Ligands, BB1, and B7 on Keratinocytes in vitro, and psoriatic cells in vivo. Am. J. Pathol. 142:1993;11040-11054.
11. Barnaba V., Watts C., de Boer M., Lane P., Lanzavecchia A. Professional presentation of antigen by activated human T cells. Eur. J. Immunol. 24:1994;71-75.
12. + T cells. Eur. J. Immunol. 26:1996;1700-1706.
13. Wyss-Coray T., Mauri-Hellweg D., Baumann K., Bettens F., Grunow R., Pichler W.J. The B7 adhesion molecule is expressed on activated human T cells: functional involvement in T-T cell interactions. Eur. J. Immunol. 23:1993;2175-2180.
14. Sansom D.M., Hall N.D. B7/BB1, the ligand for CD28 is expressed on repeatedly activated human T cells in vitro. Eur. J. Immunol. 23:1993;295-298.
15. Azuma M., Yssel H., Phillips J.H., Spits H., Lanier L.L. Functional expression of B7/BB1 on activated T lymphocytes. J. Exp. Med. 177:1993;845-850.
16. Pichler W.J., Wyss-Coray T. T cells as antigen-presenting cells. Immunol. Today. 169:1994;312-315.
17. + T cells from human immunodeficiency virus type 1-infected donors. Proc Natl. Acad. Sci. USA. 90:1993;11094-11098.
18. + cytotoxic T cells. Immunol. Res. 15:1996;126-140.
19. Fleischer J., Soeth E., Reiling N., Grage-Griebenow E., Flad H.-D., Ernst M. Differential expression and function of CD80 (B7-1) and CD86 (B7-2) on human peripheral blood momocytes. Immunology. 89:1996;592-598.
20. Daniel V., Süsal C., Weimer R., Zimmermann R., Huth-Kühne A., Opelz G. Association of T cell and macrophage dysfunction with surface gp120-immunglobulin-complement complexes in HIV-infected patients. Clin. Exp. Immunol. 93:1993;152-156.
21. + peripheral T lymphocytes and natural killer cells in the antibody-dependent cellular cytotoxity (ADCC) system. J. Immunol. 158:1997;5492-5500.
22. Chun T.W., Carruth L., Finzi D. et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature. 387:1997;183-187.
23. Lanzavecchia A., Roosnek E., Gregory T., Berman P., Abrignani S. T cells can present antigen such as HIV gp 120 targeted to their own surface molecules. Nature. 334:1988;530-532.
24. + cell depletion. Cell. 54:1988;561-575.
25. Buchbinder S.P., Katz M.H., Hessol N.A., O'Malley P.M., Holmberg S.D. Long-term HIV-1 infection without immunologic progression. AIDS. 8:1994;1123-1128.